Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer's Pathology in Preclinical Alzheimer's Disease.

MLA

Eruysal, Emily, et al. “Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer’s Pathology in Preclinical Alzheimer’s Disease.” Journal of Alzheimer’s Disease, vol. 91, no. 4, Feb. 2023, pp. 1073–83. EBSCOhost, https://doi.org/10.3233/JAD-220686.

APA

Eruysal, E., Ravdin, L., Zhang, C., Kamel, H., Iadecola, C., & Ishii, M. (2023). Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer’s Pathology in Preclinical Alzheimer’s Disease. Journal of Alzheimer’s Disease, 91(4), 1073–1083. https://doi.org/10.3233/JAD-220686

Chicago

Eruysal, Emily, Lisa Ravdin, Cenai Zhang, Hooman Kamel, Costantino Iadecola, and Makoto Ishii. 2023. “Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer’s Pathology in Preclinical Alzheimer’s Disease.” Journal of Alzheimer’s Disease 91 (4): 1073–83. doi:10.3233/JAD-220686.